TY - JOUR
T1 - Effects of photobiomodulation therapy on implant stability and postoperative recovery
T2 - a systematic review and meta-analysis
AU - Qu, Changxing
AU - Luo, Feng
AU - Hong, Guang
AU - Wan, Qianbing
N1 - Funding Information:
This study was supported by the Research and Develop Programme, West China Hospital of Stomatology, Sichuan University (RD-02-201910).
Publisher Copyright:
© 2022 The British Association of Oral and Maxillofacial Surgeons
PY - 2022/6
Y1 - 2022/6
N2 - The purpose of this study was to systemically analyse the effects of photobiomodulation therapy (PBMT) on implant stability and postoperative recovery. Electronic searches on MEDLINE (PubMed), Cochrane Library, EMBASE, and Web of Science were completed independently by two researchers in February 2021, and a manual search was performed for the references of the included articles. The primary outcome was implant stability. The secondary outcome was postoperative recovery, including postoperative pain, recovery of peri-implant hard tissue (marginal bone loss and bone mineral density), facial swelling, and peri-implant clinical parameters. Twenty studies were finally obtained (17 randomised controlled, and 3 controlled clinical studies). Meta-analysis revealed that PBMT increased implant stability at 10 days after insertion (MD 2.27, 95% CI: 0.40 to 4.13, P = 0.020), and reduced marginal bone loss at 6 months after insertion (MD −0.16, 95% CI: −0.23 to −0.08, P < 0.001). However, no significant improvements were noted in implant stability two weeks (P = 0.070), three weeks (P = 0.090), six weeks (P = 0.050), and 12 weeks (P = 0.080) after insertion. Qualitative analysis suggested that PBMT could not alleviate postoperative pain, increase bone mineral density, or improve peri-implant clinical parameters. It was effective only in reducing facial swelling. This study suggests that the effects of PBMT on implant stability and postoperative recovery may be limited.
AB - The purpose of this study was to systemically analyse the effects of photobiomodulation therapy (PBMT) on implant stability and postoperative recovery. Electronic searches on MEDLINE (PubMed), Cochrane Library, EMBASE, and Web of Science were completed independently by two researchers in February 2021, and a manual search was performed for the references of the included articles. The primary outcome was implant stability. The secondary outcome was postoperative recovery, including postoperative pain, recovery of peri-implant hard tissue (marginal bone loss and bone mineral density), facial swelling, and peri-implant clinical parameters. Twenty studies were finally obtained (17 randomised controlled, and 3 controlled clinical studies). Meta-analysis revealed that PBMT increased implant stability at 10 days after insertion (MD 2.27, 95% CI: 0.40 to 4.13, P = 0.020), and reduced marginal bone loss at 6 months after insertion (MD −0.16, 95% CI: −0.23 to −0.08, P < 0.001). However, no significant improvements were noted in implant stability two weeks (P = 0.070), three weeks (P = 0.090), six weeks (P = 0.050), and 12 weeks (P = 0.080) after insertion. Qualitative analysis suggested that PBMT could not alleviate postoperative pain, increase bone mineral density, or improve peri-implant clinical parameters. It was effective only in reducing facial swelling. This study suggests that the effects of PBMT on implant stability and postoperative recovery may be limited.
KW - Implant stability
KW - Low-level laser therapy
KW - Meta-analysis
KW - Photobiomodulation therapy
KW - Systematic review
UR - http://www.scopus.com/inward/record.url?scp=85129107533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129107533&partnerID=8YFLogxK
U2 - 10.1016/j.bjoms.2022.01.014
DO - 10.1016/j.bjoms.2022.01.014
M3 - Review article
C2 - 35490059
AN - SCOPUS:85129107533
SN - 0266-4356
VL - 60
SP - e712-e721
JO - British Journal of Oral and Maxillofacial Surgery
JF - British Journal of Oral and Maxillofacial Surgery
IS - 5
ER -